We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Peering into single cells reveals key processes in acute kidney injury (Photo courtesy of Pexels)

New Insights into Molecular Interactions Pave Way for Rapid AKI Diagnostic Tests

A research team has used single-cell sequencing techniques to uncover the molecular processes associated with acute kidney injury (AKI). The team has discovered novel gene expression patterns of injured kidney cells that may lead to new therapeutic approaches and strategies for biomarker discovery. More...
06 Oct 2022
Image: The OraQuick Ebola Rapid Antigen Test (Photo courtesy of OraSure)

Next-Gen Ebola Test to Offer Improved Sensitivity and More Automation

Efforts are now on to develop a second-generation Ebola test that would offer improved sensitivity, increased shelf life, new chemistry and more automation when compared to the current test. More...
05 Oct 2022
Image: New heart attack insight could lead to better survival rates after surgery (Photo courtesy of Imperial College London)

Troponin Testing Could Improve Timing of Heart Surgery and Survival Rate

A new study has found that some patients who have lower levels of troponin would benefit from having earlier surgery, although patients with very high troponin levels should have surgery postponed, as their risk of dying was higher if surgery was performed within 10 days of their heart attack. More...
04 Oct 2022
Image: Special blood test could determine if patient has early stage breast cancer and if the cancer is unlikely to return (Photo courtesy of USC)

Simple Blood Draw Could Revolutionize Early Breast Cancer Detection

Scientists have found indications that a special blood test called a liquid biopsy could determine whether a patient has breast cancer at its early stage and if that cancer is unlikely to return. More...
03 Oct 2022
Image: The PhasED-Seq MRD testing platform with increased sensitivity could dramatically improve patient outcomes (Photo courtesy of Foresight Diagnostics)

Liquid Biopsy Testing Platform Offers Unprecedented Sensitivity for MRD Detection

A novel liquid biopsy testing platform allows detection of minimal residual disease (MRD) with up to a 100-fold improvement in sensitivity over existing assays. More...
03 Oct 2022
Image: Phosphate’s electrical signature helps detect peptide phosphorylation (Photo courtesy of Tokyo Institute of Technology)

New Avenues for Use of Single-Molecule Detection Assays in Clinical Diagnosis

Scientists have reported the single-molecule detection of phosphorylation in peptides and the formation of an orthophosphate junction with the help of electronic signatures, opening up new avenues for the use of single-molecule detection of post-translational modifications (PTMs) in clinical diagnosis. More...
03 Oct 2022
Image: A cost-effective approach enables early-cancer detection from cell-free DNA in blood samples (Photo courtesy of UCLA)

Single Blood Test Enables Early Detection of Multiple Cancer Types

Researchers have reported successful results from an experimental cancer-detection system that appears to have overcome diagnostic challenges in a novel, cost-effective way. More...
30 Sep 2022
New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Analyzer
respons® UDS100
New
Chromogenic Culture System
InTray™ COLOREX™ ECC


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.